IP Verse

Maiwald patent opposition analysis

The comprehensive analysis of Maiwald opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Maiwald

Stay updated with the latest patent oppositions filed by Maiwald

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3858859
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 28, 2026MAIWALD
EP4188389
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 16, 2026EGIS
EP4406594
Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs ThereofMADRIGAL PHARMACEUTICALSJun 10, 2026EGIS
EP4037735
Drug Delivery DeviceAMGENJun 3, 2026MAIWALD
EP4185318
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 2, 2026NEUEFEIND
EP4185318
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 1, 2026SANDOZ
EP4385509
Migalastat Formulations Having Improved PharmacokineticsAMICUS THERAPEUTICSJun 1, 2026MAIWALD
EP4502401
Expansion Anchor And Method For Expanding The Expansion AnchorFISCHERWERKEMay 28, 2026HILTI
EP4399243
Polypropylene-Based Compositions With Transparency And Elongational PropertiesTOTALENERGIES ONETECHMay 20, 2026BOREALIS
EP4165128
A Combination Comprising Two Propylene-Based Polymers And Compositions Comprising The SameEXXONMOBIL CHEMICAL PATENTSMay 13, 2026BOREALIS

Top clients of Maiwald

Top companies who are the clients of Maiwald

CompanyTotal
MAIWALD131
OMYA62
BOREALIS55
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT34
NEUEFEIND24
SANDOZ23
BASF20
KNORR BREMSE SYSTEME FUR NUTZFAHRZEUGE19
HEXAL18
NOVAMONT18